Bioventus Inc.
US ˙ NasdaqGS ˙ US09075A1088

SecurityBVS / Bioventus Inc.
InstitutionEngineers Gate Manager LP
Latest Disclosed Ownership43,558 shares
Latest Disclosed Value $ 397,684
Engineers Gate Manager LP reports 36.77% decrease in ownership of BVS / Bioventus Inc.

On May 15, 2026 - Engineers Gate Manager LP filed a 13F-HR form disclosing ownership of 43,558 shares of Bioventus Inc. (US:BVS) valued at $397,685 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 68,889 shares of Bioventus Inc.. This represents a change in shares of -36.77% during the quarter. The current value of the position is $372,421 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F BIOVENTUS COM CL A 09075A108 43,558 -25,331 -36.77 398 -22.46 0.0050
2026-02-17 2025-12-31 13F BIOVENTUS COM CL A 09075A108 68,889 3,909 6.02 513 17.97 0.0061
2025-11-14 2025-09-30 13F BIOVENTUS COM CL A 09075A108 64,980 5,521 9.29 435 10.43 0.0050
2025-08-14 2025-06-30 13F BIOVENTUS COM CL A 09075A108 59,459 59,459 394 0.0049
2025-05-15 2025-03-31 13F BIOVENTUS COM CL A 09075A108 0 -45,817 -100.00 0 -100.00
2025-02-14 2024-12-31 13F BIOVENTUS COM CL A 09075A108 45,817 20,211 78.93 481 57.70 0.0084
2024-11-14 2024-09-30 13F BIOVENTUS COM CL A 09075A108 25,606 13,846 117.74 306 355.22 0.0060
2024-08-14 2024-06-30 13F BIOVENTUS COM CL A 09075A108 11,760 11,760 68 0.0015
2022-05-16 2022-03-31 13F BIOVENTUS COM CL A 09075A108 0 -23,293 -100.00 0 -100.00
2022-02-14 2021-12-31 13F BIOVENTUS COM CL A 09075A108 23,293 23,293 338 0.0152
2021-08-16 2021-06-30 13F BIOVENTUS COM CL A 09075A108 0 -24,118 -100.00 0 -100.00
2021-05-17 2021-03-31 13F BIOVENTUS COM CL A 09075A108 24,118 24,118 369 0.0183
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.